121
Participants
Start Date
December 26, 2018
Primary Completion Date
May 4, 2021
Study Completion Date
December 1, 2021
Placebo
"For each sexual encounter during the 4-week treatment period the study spray will be applied 5 minutes before intercourse and any excess will be wiped off prior to penetration.~Study subjects should leave at least 24 hours between each dosing."
PSD502
"For each sexual encounter during the 4-week treatment period the study spray will be applied 5 minutes before intercourse and any excess will be wiped off prior to penetration.~Study subjects should leave at least 24 hours between each dosing."
Manhattan Medical Research Practice, New York
Accumed Research Associates, Garden City
Premier Medical Group of the Hudson Valley, Poughkeepsie
Midlantic Urology, Bala-Cynwyd
Chesapeake Urology Research Associates, Towson
M3 Wake Research, Inc, Raleigh
Georgia Clinical Research, Llc, Lawrenceville
Primary Care Research, Atlanta
Suncoast Research Associates, Miami Lakes
Clinical Research Center of Florida, Pompano Beach
SunCoast Research, Miami
Imagine Research of Palm Beach County, Boynton Beach
Achieve Clinical Research, Birmingham
Coastal Clinical Research, Mobile
Regional Urology, LLC, Shreveport
Advanced Clinical Research, West Jordan
Advanced Clinical Research - Jordan Ridge Family Medicine, Salt Lake City
Jubilee Clinical Research, Inc, Las Vegas
Skyline Urology, Sherman Oaks
Boston Clinical Trials, Boston
Mens Health Boston, Chestnut Hill
Lead Sponsor
Plethora Solutions Ltd
INDUSTRY